DICLORAN 75mg Injection
ORNO 8mg/2ml Injection
PROVAS 300mg Injection
TERCICA 100mg/5ml Suspension
LACASIL 10g/15ml Syrup
LACASIL 10g Sachets
LAGITA ADVANCE 500mg + 100mg Chewable Tablets
RECADA Infants Sachet 10mg (Granules for Oral Suspension)
BISLERI-S 100mg Injections
ELEZO 100mg/5ml Syrup
D-TRES Injection 5mg/ml (200,000 IU)
D-TRES Oral Drops (400IU / Drop)
KLINT 400mg Tablets
ROLAC 100mg Capsules
LEVIJON 500mg Injection for Hepatitis & Liver
KINZ 10mg Injection
ROPO 2000 IU Injection
ICOFATE-M Tablets 500mg
SAMI Pharmaceuticals (Pvt.) Ltd, Pakistan is an established pharmaceutical manufacturer producing, since 1976, drugs of standard quality with full compliance of cGMP. With an annual turnover of US$ 220 million, SAMI is currently ranked as the 2nd largest pharmaceutical manufacturer of the Country (Source: IQVIA). Some of SAMI's brands as Novidat (Ciprofloxacin), Oxidil (Ceftriaxone), Grasil (Amikacin), 2SUM (Cefoperazone + Sulbactam), Ecasil (Linezolid), Timequin (Dihydroartemisinin + Piperaquin), Rolac (Itraconazole), Nims (Nimesulide), Movax (Tizanidine), Provas Infusion (Paracetamol Infusion 1g/100ml), Tercica (Dexibuprofen), Tonoflex-P (Tramadol + Paracetamol), Kinz (Nalbuphine), Breeky (Misoprostol), Trimetabol (Appetite Stimulant) and Lacasil (Lactitol) enjoy leadership and dominance in important therapeutic areas like anti infectives, rheumatology, narcotic analgesics, etc. SAMI follows aggressive ethical marketing through a large professional, experienced and motivated marketing team. SAMI enjoys technical collaboration and licensing arrangements with renowned European pharmaceutical manufacturers. Recently SAMI has introduced Provas Duo (Paracetamol 500mg + Ibuprofen 200mg) Tablets, which have received overwhelming response from the medical community. We have 6 other oral variants of Paracetamol to be introduced in the market soon; details can be found in the enclosed Product portfolio. SAMI has recently developed a state of the art fill-finish facility for Recombinant Proteins and Vaccines to be produced in liquid and lyophilized forms, packed in ampoules, vials and PFS from respective bulk concentrates to be imported from competent sources. This facility has been developed based on the latest guidelines of international regulatory bodies. We have a vast range of products in various dosage forms; solid, liquid, parenteral and topical. We have an extensive variety of products in anti-infective, NSAIDs and anti-ulcerant therapeutic classes. We are ranked no.1 in the market share of anti-infectives in Pakistan. Among parenteral preparations, SAMI Pharmaceuticals is ranked no.1 among all the multinational and the national corporates. We are currently exporting our finished products to different countries. Moreover, we have been doing contract manufacturing and also involved in technology transfer of finished pharmaceutical products.
- Vast range of pharmaceutical products in various dosage forms; solid
- liquid
- parenteral and topical